How much is Lexeo Therapeutics worth in 2026?

Lexeo Therapeutics has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has Lexeo Therapeutics raised?

Lexeo Therapeutics has raised N/A in total funding across 2 funding rounds.

Lexeo Therapeutics

Drug Discovery

Lexeo Therapeutics valuation and funding history | Last updated: September 9, 2021 | 2 funding rounds

Current Valuation

N/A

As of September 9, 2021

Total Funding Raised

N/A

Across 2 rounds

Last Round

Early Stage VC (Series B)

$100.0M

Last Funding

Sep 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 9, 2021	Early Stage VC (Series B)	$100.0M	N/A	-
March 13, 2024	PIPE	$95.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Lexeo Therapeutics is currently valued at N/A as of September 9, 2021.

Track Lexeo Therapeutics Valuation Updates

Get notified when Lexeo Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Lexeo Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Lexeo Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Lexeo Therapeutics Worth in 2026?

Lexeo Therapeutics is a leading private company in the Drug Discovery sector. Track Lexeo Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Lexeo Therapeutics Valuation is Determined

Private company valuations like Lexeo Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.